Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full |
_version_ | 1811309065987424256 |
---|---|
author | Alejandro Ramírez-Chacón Alejandro Ramírez-Chacón Sergi Betriu-Méndez Sergi Betriu-Méndez Ariadna Bartoló-Ibars Ariadna Bartoló-Ibars Azucena González Azucena González Azucena González Mercè Martí Mercè Martí Manel Juan Manel Juan Manel Juan |
author_facet | Alejandro Ramírez-Chacón Alejandro Ramírez-Chacón Sergi Betriu-Méndez Sergi Betriu-Méndez Ariadna Bartoló-Ibars Ariadna Bartoló-Ibars Azucena González Azucena González Azucena González Mercè Martí Mercè Martí Manel Juan Manel Juan Manel Juan |
author_sort | Alejandro Ramírez-Chacón |
collection | DOAJ |
first_indexed | 2024-04-13T09:34:41Z |
format | Article |
id | doaj.art-98ff8fd27267475b983e612e0ef9d98b |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-04-13T09:34:41Z |
publishDate | 2022-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-98ff8fd27267475b983e612e0ef9d98b2022-12-22T02:52:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10780031078003Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatmentsAlejandro Ramírez-Chacón0Alejandro Ramírez-Chacón1Sergi Betriu-Méndez2Sergi Betriu-Méndez3Ariadna Bartoló-Ibars4Ariadna Bartoló-Ibars5Azucena González6Azucena González7Azucena González8Mercè Martí9Mercè Martí10Manel Juan11Manel Juan12Manel Juan13Immunology Unit, Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, SpainLaboratory of Cellular Immunology, Institute of Biotechnology and Biomedicine (IBB), Cerdanyola del Vallès, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Sant Joan de Déu, Barcelona, SpainImmunology Unit, Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona (UAB), Cerdanyola del Vallès, SpainLaboratory of Cellular Immunology, Institute of Biotechnology and Biomedicine (IBB), Cerdanyola del Vallès, SpainImmunology Department, Hospital Cl´ınic de Barcelona, Centre de Diagnòstic Biomèdic (CDB), Barcelona, SpainImmunology Department, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) –Fundació Clínic per a la Recerca Biomèdica (FCRB) Universitat de Barcelona (UB), Barcelona, SpainImmunology Department, Hospital Sant Joan de Déu, Barcelona, Spainhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/fullT cellschimeric antigen receptor (CAR)ligandsreceptorantigenCAAR |
spellingShingle | Alejandro Ramírez-Chacón Alejandro Ramírez-Chacón Sergi Betriu-Méndez Sergi Betriu-Méndez Ariadna Bartoló-Ibars Ariadna Bartoló-Ibars Azucena González Azucena González Azucena González Mercè Martí Mercè Martí Manel Juan Manel Juan Manel Juan Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments Frontiers in Immunology T cells chimeric antigen receptor (CAR) ligands receptor antigen CAAR |
title | Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments |
title_full | Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments |
title_fullStr | Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments |
title_full_unstemmed | Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments |
title_short | Corrigendum: Ligand-based CAR T-cell: Different strategies to drive T-cells in future new treatments |
title_sort | corrigendum ligand based car t cell different strategies to drive t cells in future new treatments |
topic | T cells chimeric antigen receptor (CAR) ligands receptor antigen CAAR |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1078003/full |
work_keys_str_mv | AT alejandroramirezchacon corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT alejandroramirezchacon corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT sergibetriumendez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT sergibetriumendez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT ariadnabartoloibars corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT ariadnabartoloibars corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT azucenagonzalez corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT mercemarti corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT mercemarti corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments AT maneljuan corrigendumligandbasedcartcelldifferentstrategiestodrivetcellsinfuturenewtreatments |